Used as an intermediate in the synthesis of fluoroquinolone antibiotics, particularly in the production of advanced antimicrobial agents. Its structure supports high potency against Gram-positive and Gram-negative bacteria by inhibiting bacterial DNA gyrase and topoisomerase IV. Commonly employed in pharmaceutical research and development for creating novel derivatives with improved pharmacokinetic profiles, enhanced bioavailability, and reduced side effects. Also utilized in studies focused on overcoming bacterial resistance mechanisms in next-generation antibiotic design.